Sudeep Pharma IPO allotment today; check status, GMP, listing date

Sudeep Pharma IPO allotment: Investors can check their allotment status online through the official websites of the BSE, NSE, or MUFG Intime India

Sudeep Pharma IPO allotment: The basis of allotment for the Sudeep Pharma is expected to be finalised on Wednesday, November 26, 2025, after the issue received an overwhelming overall subscription of 93.72 times, according to NSE data. 

 

Despite a muted start amid cautious market sentiment, the ₹895-crore public offering picked up momentum on the final day, driven largely by strong demand from Qualified Institutional Buyers (QIBs). Their portion was subscribed 213.08 times, the highest among investor categories.

 

Non-institutional investors (NIIs) also showed solid interest, bidding for 116.72 times their allotted quota, while the retail segment was subscribed 15.65 times.

 

With the IPO now closed, investors are awaiting the allotment status, which is expected to be released later today.

Here's how to check Sudeep Pharma IPO allotment status 

Once the allotment is finalised, applicants can check their allotment status online through the official websites of the BSE, NSE, or MUFG Intime India, the registrar to the issue.

 

Alternatively, investors can use the following direct links to verify the Sudeep Pharma IPO allotment status:

 

• Check Sudeep Pharma IPO allotment status on BSE: bseindia.com/investors/appli_check.aspx

•  

Check Sudeep Pharma IPO allotment status on MUFG Intime India: in.mpms.mufg.com/Initial_Offer/public-issues.html

 

Check Sudeep Pharma IPO allotment status on NSE: nseindia.com/products/dynaContent/equities/ipos/ipo_login.jsp

Sudeep Pharma IPO GMP, listing date

Ahead of the allotment, Sudeep Pharma's unlisted shares were trading at around ₹680 in the grey market, reflecting a premium of ₹87 or 14.7 per cent over the upper end of the price band of ₹563 to ₹593, according to sources tracking unofficial markets.

 

The company is scheduled to debut on the bourses, BSE and NSE, on Friday, November 28, 2025.

 

Based on current grey market indications, the stock is expected to witness a positive debut; however, analysts caution that GMP movements are speculative and not a reliable predictor of actual listing performance.  ALSO READ | Fractal Analytics gets Sebi nod for ₹4,900 crore IPO; check key details

Sudeep Pharma IPO details 

Sudeep Pharma IPO opened for initial public offering (IPO) on, Friday, November 21, 2025, and closed on November 25, 2025

 

The company aimed to raise ₹895 crore through the offer, comprising a fresh issue of 1.6 million shares valued at ₹95 crore and an offer for sale of 13.5 million shares totalling ₹800 crore.

 

MUFG Intime India is the registrar for the issue. ICICI Securities and IIFL Capital Services are the book-running lead managers. 

 

According to the red herring prospectus (RHP), the company plans to use ₹75.81 crore from the net fresh issue proceeds for the procurement of machinery for the production line located at the Nandesari Facility. The remaining funds will be used for general corporate purposes.